Immuneering (IMRX) Other Working Capital Changes (2020 - 2026)

Immuneering's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$94221.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 17.57% year-over-year to -$94221.0; the TTM figure through Mar 2026 stood at -$352514.0 (down 18.08% YoY), while the FY2025 annual figure was -$338432.0, down 12.77% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$94221.0, down from -$91904.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.4 million in Q2 2022, with the low at -$1.5 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $4083.0 (2022), against an average of -$13826.7.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes soared 60.59% in 2022, then tumbled 724.65% in 2023.
• Immuneering's Other Working Capital Changes stood at -$9664.0 in 2022, then tumbled by 724.65% to -$79694.0 in 2023, then grew by 1.91% to -$78168.0 in 2024, then retreated by 17.57% to -$91904.0 in 2025, then decreased by 2.52% to -$94221.0 in 2026.
• Business Quant data shows IMRX's Other Working Capital Changes at -$94221.0 in Q1 2026, -$91904.0 in Q4 2025, and -$84230.0 in Q3 2025.